"In some of the trials, we saw that individuals who had those variants were unable to lower their blood glucose levels as effectively after six months of treatment," said Anna Gloyn, DPhil, professor of pediatrics and of genetics at Stanford Medicine and one of the study's senior authors
There is no universal schedule for every patient
Most patients administer injections five days per week
Tirzepatide Once Weekly for the Treatment of Obesity: Participants in this study complete a 60-week Weight-Loss Period on Tirzepatide, followed by a 52-week Weight Maintenance Period, where they are assigned to either Tirzepatide 5 mg, the maximum tolerated dose of Tirzepatide, and saw successful results
10.1038/sj.mp.4000805 28
Hsu FC, Zhang GJ, Raol YSH, Valentino RJ, Coulter DA, Brooks-Kayal AR